Detalhe da pesquisa
1.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Future Oncol
; 18(7): 771-779, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068173
2.
Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care.
Future Oncol
; 16(20): 1413-1415, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32406749
3.
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016).
J Immunother Cancer
; 11(11)2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016718
4.
Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial.
Clin Lung Cancer
; 22(5): 473-477, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762169
5.
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2).
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016723
6.
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Immunotherapy
; 12(15): 1139-1148, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32933369
7.
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial).
Ther Adv Med Oncol
; 12: 1758835920915983, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32733604
8.
The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials.
Expert Rev Pharmacoecon Outcomes Res
; 15(1): 101-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25399933
9.
Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro.
Br J Pharmacol
; 139(1): 21-7, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12746219
10.
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin.
Br J Pharmacol
; 138(5): 977-85, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12642400
11.
Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly.
J Chemother
; 26(2): 111-6, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24090610
12.
Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer.
Tumori
; 99(6): 650-5, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24503786
13.
Bradykinin B2 receptors mediate contraction in the normal and inflamed human gallbladder in vitro.
Gastroenterology
; 125(1): 126-35, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12851878
14.
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.
Proc Natl Acad Sci U S A
; 99(12): 8400-5, 2002 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-12060783